Anne Tsao is an Oncologist and a Hematologist in Houston, Texas. Dr. Tsao is rated as an Elite provider by MediFind in the treatment of Mesothelioma. Her top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, and Tissue Biopsy.

Bryan Burt is a General Surgeon in Houston, Texas. Dr. Burt is rated as an Elite provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Mesothelioma, Thoracic Outlet Syndrome, Thymic Epithelial Tumor, Thymectomy, and Endoscopy.

Reza Mehran is a Thoracic Surgeon and a General Surgeon in Houston, Texas. Dr. Mehran is rated as an Elite provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Hepato-Pancreato-Biliary Surgery.

David Waller is a Child and Adolescent Psychiatrist in Dallas, Texas. Dr. Waller is rated as an Elite provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Mesothelioma, Emphysema, Lung Cancer, Endoscopy, and Mastectomy.

Zhongxing Liao is a Radiation Oncologist in Houston, Texas. Dr. Liao is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, Small Cell Lung Cancer (SCLC), and Gastrostomy.

Joe Chang is a Radiation Oncologist in Houston, Texas. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Endoscopy.

Jun Zhang is a Hematologist Oncology specialist and an Oncologist in Sugar Land, Texas. Dr. Zhang is rated as an Advanced provider by MediFind in the treatment of Mesothelioma. Her top areas of expertise are Pleuropulmonary Blastoma, Laryngeal Cancer, Mesothelioma, and Non-Muscle Invasive Bladder Cancer. Dr. Zhang is currently accepting new patients.

Jianjun Zhang is an Oncologist in Houston, Texas. Dr. Zhang is rated as an Advanced provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Hepatectomy, and Endoscopy.

John Heymach is an Oncologist in Houston, Texas. Dr. Heymach is rated as an Advanced provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.

Erminia Massarelli is an Oncologist and a Hematologist in Tyler, Texas. Dr. Massarelli is rated as an Advanced provider by MediFind in the treatment of Mesothelioma. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Tissue Biopsy, and Liver Embolization.

Janet Tu is a Hematologist and an Oncologist in Houston, Texas. Dr. Tu is rated as an Advanced provider by MediFind in the treatment of Mesothelioma. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).

Shawn S. Groth, M.D. is a board-certified general thoracic surgeon in Houston who specializes in minimally invasive thoracic surgery. After finishing his cardiothoracic surgery residency under Dr. David J. Sugarbaker at the Brigham and Women’s Hospital, Harvard Medical School, Dr. Groth pursued an advanced fellowship in minimally invasive esophageal surgery at the University of Pittsburgh under the mentorship of Dr. James D. Luketich, a pioneer in minimally invasive foregut surgery. Dr. Groth seeks to bring that expertise to Baylor. As part of a team effort with other health care providers, Dr. Groth’s practice includes the multi-disciplinary management of benign and malignant disorders of the esophagus/foregut, lung, pleural space, mediastinum, chest wall, and diaphragm. As the Director of Esophageal Surgical Services at Baylor St. Luke’s Medical Center, Dr. Groth will co-direct a newly created swallow center, which will provide a multi-disciplinary approach to managing patients with gastroesophageal reflux disease and esophageal motility disorders. He provides minimally invasive approaches to managing benign (e.g., gastroesophageal reflux disease, paraesophageal hernias, achalasia, benign strictures, and esophageal diverticuli) and malignant foregut disorders (e.g., malignant strictures and esophageal and gastroesophageal junction cancers), as well as Barrett’s esophagus. Already a well-published investigator, Dr. Groth has presented his work at numerous national society meetings, including The American College of Surgeons, The American College of Chest Physicians, The American Society of Clinical Oncology, The Society of Thoracic Surgeons, and The American Association for Thoracic Surgery. Dr. Groth’s clinical research focuses on thoracic oncology outcomes research, health care disparities research, and clinical trials. He has explored several topics directed towards improving the guideline treatment of cancer patients. His basic science and translational research efforts are directed towards advancing personalized oncology. In light of the COVID-19 pandemic, the Baylor College of Medicine General Thoracic Surgery Clinic is offering telemedicine clinic visits. To schedule, please call the main line at 713-798-6376. Dr. Groth is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Mesothelioma, Achalasia, Metastatic Pleural Tumor, Endoscopy, and Gastrostomy.

Dr. R. Taylor Ripley is a professor of Surgery and the Meyer-DeBakey Chair in Investigative Surgery. He serves as director of the Mesothelioma Treatment Center, Thoracic Surgical Research, and Clinical Trials for the Michael E. DeBakey Department of Surgery. He is a nationally recognized, board-certified Thoracic Surgeon and an expert in mesothelioma, lung cancer, esophageal cancer, chest wall tumors, and chest wall reconstruction. Additionally, Dr. Ripley focuses on Costal Margin Reconstruction for Slipping Rib Syndrome. Dr. Ripley specializes in Robotic Surgery to provide minimally-invasive approaches to thoracic diseases. He also practices all aspects of thoracic surgery including infectious lung disease, benign esophageal disease, and endoluminal procedures. Dr. Ripley received the ‘Top Doctors’ award by the Houstonia Magazine and the ‘Star Faculty Award for Excellence in Patient Care'.Dr. Ripley focuses on the treatment of patients with mesothelioma in which he is the principal investigator of the actively enrolling trial, ‘NEMO: Combination of Induction Durvalumab and Tremelimumab alone versus Durvalumab and Tremelimumab with chemotherapy for Potentially Resectable Pleural Mesothelioma.’ In this trial, patients will receive the maximum treatment to beat this disease. Patients will undergo treatment with immunotherapy with or without chemotherapy, then they will undergo surgery with an extended pleurectomy decortication or extrapleural pneumonectomy, then they will receive one year of immunotherapy.Dr. Ripley leads the Ripley Lab for Translational Thoracic Oncology Research (Thoracic Surgical Oncology Translational Laboratory (bcm.edu)) in which he focuses on methods to undermine tumors ability to resist treatment. His laboratory is funded with two National Cancer Institute, NIH, R01 grants, ‘Targeting the Mitochondria to Overcome Resistance to Immune Checkpoint Inhibition in Malignant Pleural Mesothelioma,’ and ‘Novel strategies to improve mesothelioma therapy’. Additionally, he received an award from the DeGregorio Family Foundation Grant for Gastric and Esophageal Malignancies, ‘Targeting Mitochondrial Resistance to Apoptosis after Neoadjuvant Therapy in Esophageal Adenocarcinoma’ to improve treatment for patients with esophageal cancer.Prior to his faculty appointment at BCM, Dr. Ripley was an Associate Professor of Surgery at National Cancer Institute, NIH. Prior to the NIH faculty appointment, Dr. Ripley trained extensively in the care of patients with mesothelioma and thoracic cancers under world-renowned surgeons during his fellowship at Memorial Sloan-Kettering Cancer Center in New York. He also completed a fellowship in Surgical Oncology at the NCI, NIH. Dr. Ripley did general surgery residency at the University of Colorado and received his Medical Doctorate from Vanderbilt University. Dr. Ripley is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Mesothelioma, Metastatic Pleural Tumor, Fibrosing Mediastinitis, Pleuropulmonary Blastoma, and Thymectomy.

Nihar Patel is a Hematologist Oncology specialist and an Oncologist in Round Rock, Texas. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Lynch Syndrome, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Patel is currently accepting new patients.

Jenny Pozadzides is a Hematologist and an Oncologist in Houston, Texas. Dr. Pozadzides is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Neuroendocrine Tumor.

Giancarlo Moscol is an Oncologist and a Hematologist in Houston, Texas. Dr. Moscol is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Breast Cancer.

David Rubio is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Rubio is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pseudomyxoma Peritonei, COVID-19, Gastrostomy, and Endoscopy.

Kanwal Raghav is an Oncologist in Houston, Texas. Dr. Raghav is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Appendix Cancer, Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Splenectomy.

Daniel Wang is a Hematologist Oncology specialist and an Oncologist in Dallas, Texas. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Mesothelioma, Melanoma, Bone Tumor, and Liposarcoma. Dr. Wang is currently accepting new patients.

Timothy Yap is an Oncologist in Houston, Texas. Dr. Yap is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Lung Cancer, Metastatic Pleural Tumor, Ovarian Cancer, Orchiectomy, and Prostatectomy.